Abstract
Yu Xue, a Ph.D. biochemist who worked at GlaxoSmithKline’s research facility in Upper Merion, Pa., has pleaded guilty to stealing intellectual property (IP) from her former employer, according to the U.S. Department of Justice. She has not yet been sentenced. Xue planned to use the pilfered research to benefit a Chinese drug company, Renopharma, that she and her associates had set up with financial support from the Chinese government, the Justice Department says. According to the original 2016 indictment, Xue was accused of stealing IP on pharmaceuticals under development, including a monoclonal antibody similar to the cancer therapy Herceptin. Over time, the partners aimed to develop their own antibody drugs. “We cannot allow U.S. citizens or foreign nationals to steal sensitive business information and hand it over to competitors in other countries,” says William M. McSwain, the U.S. attorney for the Eastern District of Pennsylvania in Philadelphia. Trade-secret theft has
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
